Clinical Trials Browser

Phase 1 × anlotinib × Tumor-Agnostic × Clear all

NCT02752516 2017-09-18

A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics

Phase 1 Unknown

Neoplasms